一次性注射器的全球市场-2022-2029

市场动态

全球一次性注射器市场的增长受到某些因素的推动，例如各种非政府组织为提高对一次性注射器的认识而开展的活动增加、遏制艾滋病毒等疾病传播的需要以及对注射药物的需求增加。拖曳。

预计在预测期内，不断上升的交通事故将推动全球一次性注射器市场。

注射药物的使用显着增加，主要是由于传统给药方法的生物利用度不足。许多口服给药的药物在初始代谢过程中被降解，当它们到达体循环时使其失效。另一方面，注射剂直接分布在全身，因此它们可以更快地发挥作用。此外，越来越多的针刺伤也增加了对安全注射器的需求。这些优势也推动了注射器的日益普及，从而推动了全球一次性注射器市场的增长。此外，预计对疫苗的需求增加将促进注射器，特别是一次性注射器在世界发展中地区的销售。

主要包括生物製剂的注射剂领域的持续增长是全球一次性注射器市场的主要推动力。超过 60% 的临床开发药物是生物製剂。这表明生物製剂市场的强劲增长。预计这将提振一次性注射器市场。对即时管理的需求不断增长，一次性注射器製造技术的进步正在推动全球一次性注射器市场的发展。

突破性创新，例如引入两步式一次性自动注射器，正在推动全球一次性注射器市场的增长。一次性注射器市场的公司正在加大力度推出适应各种药物粘度的设备。改进设备设计以消除对定制系统组件的需求也越来越受到重视。一种新的两级一次性自动注射器克服了与集成不良的系统相关的破损和不兼容的挑战。

与一次性注射器相关的严格法规阻碍了一次性注射器市场的增长

一次性注射器在可用性和安全性方面存在若干限制，例如过敏反应、伤口擦伤和皮肤感染。它也被 FDA 归类为 II 类，在印度根据药品和化妆品法案 (1940) 归类为 B 类，这构成了需要临床试验的稍高的风险，导致进一步的法律并发症。这些材料的安全性、质量和性能需要出于公共卫生目的进行严格评估，因此需要遵守复杂而严格的附属机构规定。因此，这些因素正在阻碍一次性注射器市场的增长。

行业分析

全球一次性注射器市场根据波特五力分析、供应链分析、监管分析、定价分析和产品分析等各种行业因素对市场进行了深入分析。

全球一次性注射器市场报告提供了大约 40 多个市场数据表、45 多个数字和 180 页的结构。

内容

第1章研究方法与范围

• 调查方法
• 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

• 按产品划分的市场细分
• 按应用划分的市场细分
• 最终用户的市场细分
• 按地区划分的市场细分

第 4 章动力学

• 市场影响因素
• 驱动程序
  • 增加各种非政府组织的活动，以提高对使用一次性注射器的认识
  • 需要遏制艾滋病毒等疾病的传播
  • 对注射药物的需求不断上升
• 限制因素
  • 一次性费用相对较高
• 严格的政府法规
• 商机

第5章行业分析

• 波特五力分析
• 供应链分析
• 监管分析
• 定价分析
• 产品分析
• 售后服务分析

第 6 章按产品分类

• 常规一次性注射器
• 安全的一次性注射器
• 针
• 口服注射器
• 填充针

第 7 章按应用程序

• 疫苗注射器
• 治疗性注射

第 8 章最终用户

• 医院
• 诊断实验室
• 血库
• 製药行业
• 疫苗接种
• 兽药

第 9 章按地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲地区
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 10 章竞争格局

• 竞争场景
• 市场定位/市场份额分析
• 併购分析

第 11 章公司简介

• 百特国际公司
  • 公司简介
  • 产品组合和描述
  • 主要发展状况
  • 财务摘要
• B. Braun Melsungen AG
• Becton
• Dickinson and Company
• Cardinal Health
• Henke-Sass Wolf
• Nipro Medical Corporation
• Novo Nordisk A/S
• Retractable Technologies, Inc.
• Vita Needle Company（*List is not exhaustive）

第12章 DataM

Market Overview

Disposable Syringes Market is estimated to reach at a CAGR of 6.5% during the forecast period (2022-2029).

Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow.

Advancements in the Disposable Syringes market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Disposable Syringes is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin. A syringe designed for one-time use and is discarded after the use is called a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument that has a thin hollow needle at the end. Besides, this device acts as a pump, which is used to draw therapeutic liquid formulations from vials and deliver them to a patient's bloodstream. However, within more modern times, the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.

Market Dynamics

The global disposable syringes market growth driven by certain factors such by increasing number of activities by various NGOs that create awareness for disposable syringes, the need to control the spread of diseases like HIV, and the rising demand for injectable drugs.

Increasing incidences of road accidents, is expected to drive the global disposable syringes market during the forecast period

There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. Many orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with a quicker onset of action. Furthermore, there are rising cases of needlestick injuries that are driving the demand for safety syringes. These advantages are also responsible for the increased adoption of injectable drugs and the global disposable syringes market's consequent growth. Furthermore, the increasing demand for vaccines is expected to drive syringes' sales, particularly disposable syringes, in the developing regions of the world.

The sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% of drugs in clinical development are biologics. This indicates the strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. The rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes fuel the global disposable syringes market.

Ground breaking innovations such as introducing two-step disposable auto-injector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different drugs' viscosities. They are increasing focus to deliver design improvements in devices that eliminate the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.

Strict regulations associated with Disposable Syringes hampering the growth of the Disposable Syringes market

Disposable Syringes has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the Disposable Syringes market.

Industry Analysis

The global Disposable Syringes market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, product analysis etc.

Segment Analysis

The cyanoacrylates segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.

Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.

Geographical Analysis

North America region holds the largest market share of the global Disposable Syringes market

North America region is dominating the global Disposable Syringes market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure and experienced professionals in this region which leads to higher adoption of Disposable Syringes in hospitals, specialty clinics, and diagnostic centers. Also, growing awareness of the benefits of non-invasive medical aesthetic treatments is also boosting the growth of the market. The number of breast augmentation and liposuction procedures in the United States has always been high.

Canada's aesthetic device market is a highly diversified and export-oriented industry that manufactures equipment and supplies where purchasers include Canadian and international hospitals, physician's offices, laboratories, clinics, as well as patients (through direct purchases). The aesthetic device sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in Canadian universities, research institutes, and hospitals, some of which have been spun-off into Canadian medical device companies. Around 10% of Canada's medical device companies have spun off from Canadian research organizations.

Competitive Landscape

The global Disposable Syringes market is fragmented with the presence of a large number of market players. Some of the major players contributing to the growth of the Disposable Syringes market are Allergan Plc., Bausch Health Companies Inc., Cutera Palomar Medical Technologies, Cynosure Inc., Fosun International Ltd., Fotona Inc., Lutronic Inc., Sciton Inc., among others. Rising awareness toward aesthetic-based skin and body rejuvenation lasers and energy devices have increased the revenue opportunities for leading manufacturers to invest in the Disposable Syringes market.

The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Disposable Syringes market globally. For instance,

• In August 2020, the US-based Sensus Healthcare has acquired mobile aesthetic laser companies Aesthetic Mobile Laser Services and Aesthetic Laser Partners in Florida, US. The transactions are expected to bring in approximately $1m in revenues over the next 12 months.
• In May 2020, AbbVie has completed the acquisition of Allergan. AbbVie planning to launch Allergan Aesthetics, a global subsidiary under the umbrella of the AbbVie-Allergan merger.
• In November 2019, Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT, and gynecology from XIO. The transaction values Lumenis at an enterprise value of over $1 billion.

Key Companies to Watch

Allergan Plc

Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Product Portfolio: CoolTone Device- The CoolTone device is FDA-cleared for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.

The global Disposable Syringes market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by End-User
• 3.4. Market Snippet by Region

4. Dynamics

• 4.1. Market Impacting Factors
• 4.2. Drivers
  • 4.2.1. Increasing Activities by Various NGO's that Create Awareness for the Use of Disposable Syringes
  • 4.2.2. Need to Control the Spread of Diseases like HIV
  • 4.2.3. Rising Demand for Injectable Drugs
• 4.3. Restraints
  • 4.3.1. Comparatively High One-time Cost
• 4.4. Stringent Government Regulations
• 4.5. Opportunity

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Pricing Analysis
• 5.5. Product Analysis
• 5.6. Post Sales Services Analysis

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Conventional Disposable Syringes *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 6.3. Safety Disposable Syringes
• 6.4. Needles
• 6.5. Oral Syringes
• 6.6. Filling Needles

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Immunization injections
• 7.3. Introduction
• 7.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 7.5. Therapeutic injections

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals
• 8.3. Introduction
• 8.4. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
• 8.5. Diagnostic Laboratories
• 8.6. Blood Banks
• 8.7. Pharmaceutical Industry
• 8.8. Vaccination
• 8.9. Veterinary Purposes

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. The U.S.
    • 9.2.7.2. Canada
    • 9.2.7.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. The U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
  • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia Pacific
• 9.6. The Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Baxter International Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Developments
  • 11.1.4. Financial Overview
• 11.2. B. Braun Melsungen AG
• 11.3. Becton
• 11.4. Dickinson and Company
• 11.5. Cardinal Health
• 11.6. Henke-Sass Wolf
• 11.7. Nipro Medical Corporation
• 11.8. Novo Nordisk A/S
• 11.9. Retractable Technologies, Inc.
• 11.10. Vita Needle Company (*List is not exhaustive)

12. DataM Intelligence

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us